The store will not work correctly when cookies are disabled.
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4flurophenyl)4-oxobutan-1-one
ID: ALA3318852
Chembl Id: CHEMBL3318852
Cas Number: 34104-51-3
PubChem CID: 21559988
Max Phase: Preclinical
Molecular Formula: C21H21ClFNO3
Molecular Weight: 389.85
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCC(=O)N1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
Standard InChI: InChI=1S/C21H21ClFNO3/c22-17-5-3-16(4-6-17)21(27)11-13-24(14-12-21)20(26)10-9-19(25)15-1-7-18(23)8-2-15/h1-8,27H,9-14H2
Standard InChI Key: CPIWUAZRERXKBW-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 389.85 | Molecular Weight (Monoisotopic): 389.1194 | AlogP: 3.95 | #Rotatable Bonds: 5 |
Polar Surface Area: 57.61 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.96 | CX Basic pKa: ┄ | CX LogP: 2.71 | CX LogD: 2.71 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.79 | Np Likeness Score: -1.07 |
References
1. Salama I, Löber S, Hübner H, Gmeiner P.. (2014) Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors., 24 (16): [PMID:25047579] [10.1016/j.bmcl.2014.06.079] |